etoposide has been researched along with Lymphoma, T-Cell in 97 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 19 (19.59) | 18.2507 |
| 2000's | 39 (40.21) | 29.6817 |
| 2010's | 29 (29.90) | 24.3611 |
| 2020's | 10 (10.31) | 2.80 |
| Authors | Studies |
|---|---|
| Akiyama, M; Goto, H; Hasegawa, D; Honda, T; Kumamoto, T; Ogawa, S; Takagi, M; Terao, YM; Yamaoka, M; Yoshida, K | 1 |
| Chen, L; Chu, X; Liu, X; Wang, Y; Xu, L | 1 |
| Feng, X; Gao, Y; Jin, M; Li, H; Li, Z; Shi, C; Song, W; Zhang, L; Zhang, M | 1 |
| Chan, EHL; Chan, JYS; Chang, EWY; Chee, YL; de Mel, S; Diong, C; Farid, M; Goh, AZK; Goh, YT; Grigoropoulos, NF; Jeyasekharan, A; Khoo, LP; Lee, J; Lee, YS; Lim, C; Lim, ST; Liu, X; Nagarajan, C; Poon, E; Poon, M; Quek, R; Somasundaram, N; Tan, D; Tang, T; Tao, M; Tay, T; Yang, VSW | 1 |
| Cui, T; Meng, G; Wang, J; Wang, Z | 1 |
| Fu, R; Liang, Y; Liu, X; Piao, Y; Wang, L; Wei, L | 1 |
| Antonioli, E; Bosi, A; Fani, A; Puccini, B; Sordi, B | 1 |
| Biancon, G; Carniti, C; Cavanè, A; Corradini, P; Dugo, M; Magni, M; Paolizzi, C; Rizzitano, S | 1 |
| Au-Yeung, R; Chan, TSY; Ip, AHW; Kwong, YL; Pang, AWK | 1 |
| Gloude, N; Lauhan, CR; Schiff, D | 1 |
| Lansigan, F; LeBlanc, RE | 1 |
| Chan, JY; Farid, M; Lim, C; Lim, ST; Martin, P; Poon, E; Somasundaram, N; Tang, T; Tao, M; Toh, SQ; Yan, SX; Yunon, MJ | 1 |
| Ailawadhi, S; Dholaria, B; Patel, RJ; Roy, V; Sluzevich, JC | 1 |
| Anticoli-Borza, P; Arcari, A; Battistini, R; Bocci, G; Casaroli, I; Cox, MC; di Landro, F; Fabbri, F; Merli, F; Musuraca, G; Naso, V; Tafuri, A; Zoli, V | 1 |
| Hiroshima, Y; Joshita, S; Kawata, K; Kimura, T; Kobayashi, H; Mori, H; Tanaka, E; Tanaka, N; Umemura, T; Wada, S; Wakabayashi, SI | 1 |
| Fan, L; Li, JY; Li, W; Liang, JH; Lu, L; Xu, W; Zhu, HY | 1 |
| Fujimoto, M; Maruyama, H; Okiyama, N; Saito, A; Tanaka, R | 1 |
| Ashrani, AA; Higgins, AS; Hoversten, KP | 1 |
| Ichimura, Y; Kamata, M; Kamikubo, Y; Kurokawa, M; Mitsui, H; Miyagaki, T; Sato, S; Sonoda, K; Sugaya, M | 1 |
| Chalmers, AW; Gregory, SA; Katz, DA; Miller, IJ | 1 |
| Shustov, A | 1 |
| Chim, CS; Kwong, YL; Leung, AY; Pang, AW; Tse, E | 1 |
| Czajczynska, A; Gramatzki, M; Günther, A; Humpe, A; Kneba, M; Nickelsen, M; Raff, T; Repp, R; Schrappe, M; Schrauder, A; Schub, N | 1 |
| Kraus, TS; Tan, BT; Twist, CJ | 1 |
| Mayson, E; Saverimuttu, J; Warburton, P | 1 |
| Barosi, G; Billio, A; Corradini, P; Gallamini, A; Marchetti, M; Pileri, S; Pimpinelli, N; Rossi, G; Tura, S; Zinzani, PL | 1 |
| Chan, WK; Huang, B; Khong, PL; Kwong, YL; Lee, EY | 1 |
| Thia, K; Trapani, JA; Voskoboinik, I | 1 |
| Bae, SH; Chung, J; Heo, DS; Hyun, MS; Jeon, YK; Kang, YK; Kim, BS; Kim, CW; Kim, DW; Kim, H; Kim, HJ; Kim, TM; Lee, JS; Song, HS; Yang, SH; Yuh, YJ | 1 |
| Chen, S; Guan, M; Jia, N; Shao, Y; Wang, Y | 1 |
| Abdul Wahid, FS; Mashuri, F; Masir, N; Mohammed, F; Tan, GC; Tumian, NR; Wan Jamaluddin, WF; Yap, E | 1 |
| Lin, N; Liu, W; Ping, L; Song, Y; Tu, M; Wang, X; Xie, Y; Ying, Z; Zhang, C; Zheng, W; Zhu, J | 1 |
| Fujisawa, S; Hagihara, M; Ishii, Y; Itabashi, M; Matsumoto, K; Motohashi, K; Numata, A; Yamamoto, W | 1 |
| Abdul-Hay, M; Ma, H | 1 |
| Ke, XY; Wan, WL; Wang, J; Zhang, W; Zhu, MX | 1 |
| Glass, B; Leithaeuser, M; Metzner, B; Mueller-Hermelink, HK; Nickelsen, M; Pfreundschuh, M; Schmitz, N; Zeynalova, S; Ziepert, M | 1 |
| Chott, A; Friedrich, C; Janka-Schaub, G; Kabisch, H; Schrum, J | 1 |
| Ikegame, K; Imai, Y; Inoue, D; Kimura, T; Kurata, M; Matsushita, A; Mori, M; Nagai, K; Nagai, Y; Ogawa, H; Shimoji, S; Tabata, S; Takahashi, T; Togami, K | 1 |
| Yamaguchi, M | 1 |
| He, XX; Huang, JJ; Huang, Y; Li, ZM; Lin, TY; Tian, Y; Xiao, J | 1 |
| Al Awadi, S; Al Shemmari, S; Bajciova, V; Mottl, H; Nemec, J | 1 |
| Arima, F; Kataoka, I; Kobayashi, Y; Matsuno, Y; Nishimoto, J; Shimoda, T; Tamura, R; Tobinai, K; Watanabe, T; Yamamoto, S | 1 |
| Imai, K; Kazama, Y; Nakahara, S; Okada, Y; Sasaki, S; Shimizu, H; Takahashi, T; Tsujisaki, M; Yoshimoto, M | 1 |
| Avilés, A; Calva, A; Fernández, R; Huerta-Guzmán, J; Nambo, MJ; Neri, N | 1 |
| Hagimoto, T; Kanda, M; Maeda, K; Ohshima, K; Okada, M; Sakamoto, A; Sonoda, T; Suzumiya, J; Tamura, K; Wakamatsu, S | 1 |
| Bittner, S; Kloess, M; Loeffler, M; Pfreundschuh, M; Reiser, M; Rudolph, C; Schmalenberg, H; Schmits, R; Truemper, L; Wunderlich, A | 1 |
| Fujii, S; Fujino, H; Hino, M; Hirai, M; Inoue, T; Sako, M; Teshima, H; Yagi, T | 1 |
| Horiuhi, T; Ichinohasama, R; Nomura, J; Okuda, M | 1 |
| Endo, T; Fujimoto, K; Haseyama, Y; Itoh, T; Koike, T; Koizumi, K; Nishio, M; Sawada, K; Yokota, K | 1 |
| Nishimura, J; Ohshima, K; Shiokawa, S; Shiratsuchi, M; Suehiro, Y; Yoshikawa, Y | 1 |
| Feller, AC; Glass, B; Hasenclever, D; Hossfeld, DK; Kloess, M; Loeffler, M; Metzner, B; Pfreundschuh, M; Reiser, M; Rübe, C; Rudolph, C; Schmits, R; Schmitz, N; Trümper, L | 1 |
| Eimermacher, H; Feller, AC; Hasenclever, D; Hossfeld, DK; Kloess, M; Loeffler, M; Pfreundschuh, M; Reiser, M; Rübe, C; Rudolph, C; Schmits, R; Schmitz, N; Trümper, L | 1 |
| Kitanishi, T; Kitano, H; Kouzaki, H; Suzuki, M | 1 |
| Hoang-Xuan, K; Levy, V; Soussain, C | 1 |
| Chott, A; Drach, J; Hejna, M; Hoffmann, M; Püspök, A; Raderer, M; Wöhrer, S | 1 |
| Sadahira, Y; Suemori, S; Sugihara, T; Tsujioka, T; Wada, H | 1 |
| Carde, P; Ferme, C; Girinsky, T; Koscielny, S; Lapusan, S; Ribrag, V | 1 |
| Cho, KJ; Cho, SG; Lee, DH | 1 |
| Gou, HF; Hou, M; Li, L; Qiu, M; Yan, X; Zhu, J | 1 |
| Im, YH; Jung, CW; Kang, JH; Kang, WK; Kim, K; Kim, WS; Ko, YH; Lee, J; Lee, MH; Lee, SH; Park, BB; Park, JO; Park, K; Park, KW; Park, YS | 1 |
| Fan, Y; Huang, ZY; Luo, LH; Yu, HF | 1 |
| Cai, QQ; Guan, ZZ; Huang, HQ; Jiang, WQ; Lin, TY; Lin, XB; Pan, ZH; Peng, YL; Xia, YF; Xia, ZJ | 1 |
| Bentz, M; Berdel, WE; Feller, A; Glass, B; Kloess, M; Loeffler, M; Pfreundschuh, M; Schlimok, G; Schmitz, N; Trümper, L | 1 |
| Isaka, S; Kobayashi, T; Masuya, M; Miyazaki, K; Nakamura, S; Nakase, K; Shiku, H; Yamaguchi, M | 1 |
| Bang, YJ; Heo, DS; Im, SA; Kim, BK; Kim, DW; Kim, NK; Kim, TY; Lee, KW; Park, S; Yoon, SS; Yun, T | 1 |
| Hatanaka, K; Ichii, M; Imakita, M; Kishino, B; Tamaki, T; Ueda, Y | 1 |
| Bo, LJ; Chen, YH; Jin, XP; Liang, AB; Liu, B; Wang, F | 1 |
| Ichioka, M; Ishiga, T; Saito, K; Tanigawa, M | 1 |
| Andresen, S; Bolwell, BJ; Brown, S; Dean, R; Hsi, ED; Kalaycio, M; Pohlman, B; Rybicki, LA; Smith, SD; Sobecks, R; Sweetenham, JW | 1 |
| Al-Ejeh, F; Brown, MP; Darby, JM; Diener, KR; Hayball, JD; Pensa, K | 1 |
| Chapman, CS; Ghosh, K; Murphy, P; Sivakumaran, M; Wood, JK | 1 |
| Ezoe, A; Fujisaki, Y; Hayashi, S; Kohda, K; Nakazawa, O; Takayanagi, N; Takeda, M; Takimoto, R; Tsuji, A; Tsuji, Y | 1 |
| Gadner, H; Henze, G; Ludwig, WD; Müller-Weihrich, S; Parwaresch, R; Reiter, A; Riehm, H; Sauter, S; Schrappe, M; Sykora, KW | 1 |
| Egami, K; Furusawa, S; Mikuni, C; Mori, M; Nomura, T; Shimoyama, M; Sugimoto, T; Suzuki, K; Takagi, T; Yoshida, T | 1 |
| Iida, H; Iida, M; Kodera, Y; Minami, S; Seto, M; Sugihara, T; Suzuki, R; Taji, H; Ueda, R; Yamamoto, K | 1 |
| Chen, RL; Cheng, AL; Su, IJ; Wang, CH | 1 |
| Enomoto, H; Horiuchi, A; Irimajiri, K; Shirakawa, C; Tanaka, H; Yonekawa, S | 1 |
| Bergmann, L; Hoelzer, D; Jäger, E; Karakas, T; Knuth, A; Mitrou, PS; Stutte, HJ; Weidmann, E | 1 |
| Allione, A; Bernabei, P; Forni, G; Novelli, F; Rigamonti, L | 1 |
| Amiot, L; Caulet-Maugendre, S; Diebold, J; Drénou, B; Fardel, O; Fauchet, R; Lamy, T; Le Prisé, PY; Sasportes, M | 1 |
| Kizaki, H; Oguro, M; Onishi, Y | 1 |
| Hizawa, Y; Itoh, J; Kawamura, S; Munakata, A; Nakui, Y; Saitoh, S; Satoh, T; Taka-mi, H; Tamura, Y; Tsushima, K | 1 |
| Allan, DR; Bernstein, CN; Greenberg, H; Johnston, JB; Pimentel, M | 1 |
| Bloom, SE; Muscarella, DE; Rachlinski, MK; Sotiriadis, J | 1 |
| Astori, C; Bernasconi, C; Bernasconi, P; Lazzarino, M; Orlandi, E | 1 |
| Bättig, B; Cerny, T; Cogliatti, SB; Fey, MF; Kappeler, A; Laissue, JA; Mueller-Garamvoelgyi, E; Schmid, U | 1 |
| Kobzdej, M; Matuszyk, J; Strzadala, L | 1 |
| Sakai, C; Takagi, T; Tamaru, J; Tsujimura, H | 1 |
| Dobie, D; Hastings, M; Mahendra, P; Richardson, G; Tauro, S | 1 |
| Fujimori, Y; Itoh, T; Kakishita, E; Mori, A; Nishimura, Y; Okada, M; Okamoto, T; Saheki, K; Takatsuka, H; Tamura, A; Wada, H; Yamada, S | 1 |
| Achour, E; Azar, N; Belanger, C; Cassoux, N; Delattre, JY; Gerber, S; Hoang-Xuan, K; Leblond, V; Levy, V; Ribrag, V; Soussain, C; Suzan, F | 1 |
| Asahina, A; Nakamura, K; Sugaya, M; Tamaki, K | 1 |
| Houghton, JB; O'Donoghue, DJ; O'Riordan, E; Reeve, R; Waldek, S | 1 |
| Harada, M; Mizoguchi, K; Moriwaki, A; Noguchi, T; Ogino, T; Okada, S; Tsuchiyama, J; Uno, M; Yoshino, T | 1 |
| Dommann-Scherrer, C; Hassam, S; Maurer, R; Odermatt, BF; Risti, B; Zimmermann, D | 1 |
| Agthe, A; Brittinger, G; Engelhard, M; Griesser, H; Huhn, D; Kuse, R; Lennert, K; Schwerdtfeger, R; Siegert, W; Tiemann, M | 1 |
| Iki, S; Mitani, K; Ohbayashi, Y; Sato, H; Tamura, M; Urabe, A; Yagisawa, M | 1 |
6 review(s) available for etoposide and Lymphoma, T-Cell
| Article | Year |
|---|---|
Hepatosplenic T-cell lymphoma: is cure possible?
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Etoposide; Female; Humans; Liver; Lymphoma, T-Cell; Methylprednisolone; Spleen; Stem Cell Transplantation | 2013 |
T-cell lymphomas, a challenging disease: types, treatments, and future.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Killer Cells, Natural; Lymphoma, T-Cell; Prednisone; Stem Cell Transplantation; Transplantation, Homologous; Vincristine | 2017 |
[Concurrent chemoradiotherapy for localized nasal NK/T-cell lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Clinical Trials as Topic; Combined Modality Therapy; Dexamethasone; Etoposide; Female; Humans; Ifosfamide; Japan; Killer Cells, Natural; Korea; Lymphoma, T-Cell; Male; Nose Neoplasms; Prospective Studies; Radiotherapy Dosage; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome | 2010 |
Natural killer T-cell lymphoma of the tongue.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Humans; Killer Cells, Natural; Lymphoma, T-Cell; Male; Methotrexate; Prednisone; Radiotherapy, Adjuvant; Tongue Diseases; Tongue Neoplasms; Ulcer; Vincristine | 2005 |
Hemophagocytic syndrome in Epstein-Barr virus-associated T-lymphoproliferative disorders: disease spectrum, pathogenesis, and management.
Topics: Adult; Bone Marrow Transplantation; Child; Etoposide; Herpesviridae Infections; Herpesvirus 4, Human; Histiocytosis, Non-Langerhans-Cell; Humans; Immunoglobulins, Intravenous; Lymphoid Tissue; Lymphokines; Lymphoma, T-Cell; Lymphoproliferative Disorders; T-Lymphocytes; Tumor Virus Infections | 1995 |
Primary adrenal lymphoma associated with adrenal insufficiency: a distinct clinical entity.
Topics: Addison Disease; Adrenal Cortex Neoplasms; Adrenal Gland Diseases; Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cosyntropin; Cyclophosphamide; Dexamethasone; Diagnosis, Differential; Doxorubicin; Etoposide; Eye Neoplasms; Fatal Outcome; Humans; Hydrocortisone; Hyperkalemia; Ifosfamide; L-Lactate Dehydrogenase; Lymphoma, T-Cell; Male; Methotrexate; Neoplasm Proteins; Oculomotor Muscles; Prednisone; Tomography, X-Ray Computed; Tuberculosis, Endocrine; Vincristine | 1997 |
19 trial(s) available for etoposide and Lymphoma, T-Cell
| Article | Year |
|---|---|
Phase I study of selinexor in combination with dexamethasone, ifosfamide, carboplatin, etoposide chemotherapy in patients with relapsed or refractory peripheral T-cell or natural-killer/T-cell lymphoma
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Dexamethasone; Etoposide; Humans; Hydrazines; Ifosfamide; Lymphoma, T-Cell; Neoplasm Recurrence, Local; Triazoles | 2021 |
Midtreatment ¹⁸F-FDG PET/CT Scan for Early Response Assessment of SMILE Therapy in Natural Killer/T-Cell Lymphoma: A Prospective Study from a Single Center.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Etoposide; Female; Fluorodeoxyglucose F18; Humans; Ifosfamide; Lymphoma, T-Cell; Male; Methotrexate; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Prednisolone; Prospective Studies; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Young Adult | 2014 |
A phase II study of ifosfamide, methotrexate, etoposide, and prednisolone for previously untreated stage I/II extranodal natural killer/T-cell lymphoma, nasal type: a multicenter trial of the Korean Cancer Study Group.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Etoposide; Female; Humans; Ifosfamide; Killer Cells, Natural; Lymphoma, T-Cell; Male; Methotrexate; Middle Aged; Nose Neoplasms; Prednisolone; Republic of Korea; Treatment Outcome; Young Adult | 2014 |
Topotecan combined with Ifosfamide, Etoposide, and L-asparaginase (TIEL) regimen improves outcomes in aggressive T-cell lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Disease-Free Survival; Etoposide; Female; Humans; Ifosfamide; Kaplan-Meier Estimate; Lymphoma, T-Cell; Male; Middle Aged; Topotecan; Treatment Outcome; Young Adult | 2015 |
High-dose CHOP plus etoposide (MegaCHOEP) in T-cell lymphoma: a comparative analysis of patients treated within trials of the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL).
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Humans; Lymphoma, T-Cell; Male; Middle Aged; Prednisone; Prognosis; Vincristine | 2009 |
Nasal NK/T-cell lymphoma with disseminated disease treated with aggressive combined therapy.
Topics: Adult; Aged; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Neoplasms; Cyclophosphamide; Dexamethasone; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Killer Cells, Natural; Leucovorin; Lung Neoplasms; Lymphoma, T-Cell; Male; Methotrexate; Middle Aged; Nose Neoplasms; Radiotherapy, Adjuvant; Remission Induction; Skin Neoplasms; Treatment Outcome | 2003 |
Practicability and acute haematological toxicity of 2- and 3-weekly CHOP and CHOEP chemotherapy for aggressive non-Hodgkin's lymphoma: results from the NHL-B trial of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL).
Topics: Acute Disease; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Female; Germany; Granulocyte Colony-Stimulating Factor; Hematologic Diseases; Humans; L-Lactate Dehydrogenase; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Male; Middle Aged; Prednisolone; Prednisone; Recombinant Proteins; Survival Rate; Vincristine | 2003 |
Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of young patients with good-prognosis (normal LDH) aggressive lymphomas: results of the NHL-B1 trial of the DSHNHL.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease Progression; Doxorubicin; Drug Administration Schedule; Etoposide; Factor Analysis, Statistical; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; L-Lactate Dehydrogenase; Lymphoma, B-Cell; Lymphoma, T-Cell; Middle Aged; Prednisone; Prognosis; Recombinant Proteins; Survival Rate; Time Factors; Treatment Outcome; Vincristine | 2004 |
Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of elderly patients with aggressive lymphomas: results of the NHL-B2 trial of the DSHNHL.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Lymphoma, B-Cell; Lymphoma, T-Cell; Male; Middle Aged; Neoplasm Staging; Prednisone; Survival Rate; Time Factors; Treatment Outcome; Vincristine | 2004 |
Chemotherapy with cyclophosphamide, doxorubicin, etoposide, vincristine and prednisone (CHOEP) is not effective in patients with enteropathy-type intestinal T-cell lymphoma.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Injections, Intravenous; Intestinal Neoplasms; Leukopenia; Lymphoma, T-Cell; Male; Middle Aged; Neoplasm Staging; Neutropenia; Prednisone; Prognosis; Survival Rate; Treatment Outcome; Vincristine | 2004 |
Phase II study of concomitant chemoradiotherapy in bulky refractory or chemoresistant relapsed lymphomas.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Lymphoma, B-Cell; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Male; Middle Aged; Radiotherapy Dosage; Recurrence; Survival Rate | 2005 |
[Clinical randomized comparative trial of ProMACE-CytaBOM regimen and CHOP regimen in treating non-Hodgkin's lymphoma].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Humans; Leukopenia; Lymphoma, B-Cell; Lymphoma, T-Cell; Male; Methotrexate; Middle Aged; Nausea; Prednisone; Remission Induction; Survival Rate; Thrombocytopenia; Vincristine | 2005 |
Dose-escalated CHOP plus etoposide (MegaCHOEP) followed by repeated stem cell transplantation for primary treatment of aggressive high-risk non-Hodgkin lymphoma.
Topics: Adult; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Lymphoma, B-Cell; Lymphoma, T-Cell; Male; Middle Aged; Prednisone; Retrospective Studies; Risk Factors; Stem Cell Transplantation; Transplantation, Autologous; Vincristine | 2006 |
[NEO-MACOP-B chemotherapy for the treatment of advanced-stage aggressive non-Hodgkin's lymphoma].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Male; Methotrexate; Middle Aged; Mitoxantrone; Prednisolone; Remission Induction; Vincristine | 1993 |
Non-Hodgkin's lymphomas of childhood and adolescence: results of a treatment stratified for biologic subtypes and stage--a report of the Berlin-Frankfurt-Münster Group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Child, Preschool; Clinical Protocols; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Etoposide; Follow-Up Studies; Humans; Ifosfamide; Infant; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Large-Cell, Anaplastic; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Time Factors | 1995 |
[Late phase II study with 21-consecutive-day oral administration of etoposide for malignant lymphoma].
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Drug Administration Schedule; Etoposide; Female; Humans; Leukopenia; Lymphoma, B-Cell; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Male; Middle Aged; Treatment Outcome | 1994 |
Peripheral T-cell lymphomas respond well to vincristine, adriamycin, cyclophosphamide, prednisone and etoposide (VACPE) and have a similar outcome as high-grade B-cell lymphomas.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Male; Middle Aged; Prednisone; Treatment Outcome; Vincristine | 1996 |
Results of intensive chemotherapy followed by hematopoietic stem-cell rescue in 22 patients with refractory or recurrent primary CNS lymphoma or intraocular lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Central Nervous System Neoplasms; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Disease-Free Survival; Dose-Response Relationship, Drug; Etoposide; Eye Neoplasms; Feasibility Studies; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Large-Cell, Immunoblastic; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Nervous System Diseases; Salvage Therapy; Thiotepa | 2001 |
Treatment of angioimmunoblastic lymphadenopathy (AILD)-type T-cell lymphoma using prednisone with or without the COPBLAM/IMVP-16 regimen. A multicenter study. Kiel Lymphoma Study Group.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Immunoblastic Lymphadenopathy; Lymphoma, T-Cell; Male; Methotrexate; Middle Aged; Prednisone; Procarbazine; Prospective Studies; Survival Analysis; Vincristine | 1992 |
72 other study(ies) available for etoposide and Lymphoma, T-Cell
| Article | Year |
|---|---|
Successful treatment of hepatosplenic T-cell lymphoma with fludarabine, high-dose cytarabine and subsequent unrelated umbilical cord blood transplantation.
Topics: Child, Preschool; Cord Blood Stem Cell Transplantation; Cyclin-Dependent Kinase Inhibitor p16; Cyclophosphamide; Cytarabine; DNA-Binding Proteins; Etoposide; ETS Translocation Variant 6 Protein; Female; Gene Deletion; Humans; Liver Neoplasms; Lymphoma, T-Cell; PAX5 Transcription Factor; Prognosis; Proto-Oncogene Proteins c-ets; Remission Induction; Repressor Proteins; Splenic Neoplasms; Transplantation Conditioning; Treatment Outcome; Vidarabine; Whole-Body Irradiation | 2022 |
Successful treatment of hemophagocytic syndrome in a patient with T cell lymphoma, EBV infection, and bone marrow necrosis: A case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bone Marrow; Cyclophosphamide; Drug Therapy, Combination; Epirubicin; Epstein-Barr Virus Infections; Etoposide; Glucocorticoids; Herpesvirus 4, Human; Humans; Lymphohistiocytosis, Hemophagocytic; Lymphoma, T-Cell; Male; Middle Aged; Positron-Emission Tomography; Rituximab; Treatment Outcome; Vincristine | 2022 |
The potential efficacy and mechanism of bendamustine in entra-nodal NK/T cell lymphoma.
Topics: Animals; Apoptosis; Ataxia Telangiectasia Mutated Proteins; Bendamustine Hydrochloride; Caspases; Cell Line, Tumor; Cell Proliferation; Cyclin B1; Etoposide; Humans; Lymphoma; Lymphoma, T-Cell; Mice; Poly(ADP-ribose) Polymerase Inhibitors; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Ribose; Tumor Suppressor Protein p53 | 2022 |
Treatment outcomes of T and natural-killer/T-cell lymphoma with ifosfamide, carboplatin and etoposide chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Humans; Ifosfamide; Lymphoma; Lymphoma, T-Cell; Retrospective Studies; Treatment Outcome | 2022 |
Clinical characteristics and treatment of NK/T-cell lymphoma-associated HLH.
Topics: Dexamethasone; Etoposide; Humans; Lactate Dehydrogenases; Lymphohistiocytosis, Hemophagocytic; Lymphoma; Lymphoma, T-Cell; Retrospective Studies | 2022 |
Combination of gemcitabine, pegaspargase, etoposide, and dexamethasone (GPED) in treatment of advanced extranodal NK/T-cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Dexamethasone; Etoposide; Gemcitabine; Humans; Lymphoma, Extranodal NK-T-Cell; Lymphoma, T-Cell; Neoplasm Staging; Treatment Outcome | 2023 |
Chemotherapy-related nail toxicity.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lymphoma, T-Cell; Middle Aged; Nails; Nails, Malformed; Prednisolone; Vincristine | 2019 |
Tyrosine kinase inhibition to improve anthracycline-based chemotherapy efficacy in T-cell lymphoma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Cycle; Cell Survival; Cyclophosphamide; Dasatinib; Doxorubicin; Drug Administration Schedule; Drug Synergism; Etoposide; Gene Expression; Gene Expression Profiling; Humans; Jurkat Cells; Lymphoma, T-Cell; Mice, Inbred NOD; Mice, SCID; Prednisone; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-fyn; Receptors, Antigen, T-Cell; rhoA GTP-Binding Protein; Treatment Outcome; Up-Regulation; Vincristine | 2019 |
Unique evolution of angioimmunoblastic T cell lymphoma to Epstein-Barr virus-positive plasma cell myeloma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Brentuximab Vedotin; Cyclophosphamide; Doxorubicin; Epstein-Barr Virus Infections; Etoposide; Herpesvirus 4, Human; Humans; Lenalidomide; Lymphoma, T-Cell; Male; Neoplasms, Second Primary; Positron Emission Tomography Computed Tomography; Prednisolone; Vincristine | 2020 |
Successful treatment of hepatosplenic T cell lymphoma in an adolescent with Turner syndrome using ifosfamide, carboplatin, and etoposide followed by allogeneic hematopoietic stem cell transplant.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Liver Neoplasms; Lymphoma, T-Cell; Prognosis; Splenic Neoplasms; Turner Syndrome | 2020 |
Unraveling subcutaneous panniculitis-like T-cell lymphoma: An association between subcutaneous panniculitis-like T-cell lymphoma, autoimmune lymphoproliferative syndrome, and familial hemophagocytic lymphohistiocytosis.
Topics: Adult; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Autoimmune Lymphoproliferative Syndrome; Biopsy; Bone Marrow; Bone Marrow Transplantation; CD8-Positive T-Lymphocytes; Combined Modality Therapy; Dexamethasone; Etoposide; Female; Hepatitis A Virus Cellular Receptor 2; Humans; Lymphadenopathy; Lymphohistiocytosis, Hemophagocytic; Lymphoma, T-Cell; Munc18 Proteins; Mutation; Panniculitis; Transplantation, Homologous; Treatment Outcome | 2021 |
Relapsed subcutaneous panniculitis-like T cell lymphoma: role of haploidentical hematopoietic stem cell transplant.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Histocompatibility; Humans; Ifosfamide; Lupus Erythematosus, Systemic; Lymphoma, T-Cell; Nephrosis, Lipoid; Nephrotic Syndrome; Panniculitis; Paraneoplastic Syndromes; Prednisolone; Recurrence; Remission Induction; Salvage Therapy; Vincristine | 2017 |
Aggressive lymphomas of the elderly: the DEVEC metronomic chemotherapy schedule fits the unfit.
Topics: Administration, Metronomic; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Drug Administration Schedule; Etoposide; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, T-Cell; Male; Middle Aged; Organic Chemicals; Retrospective Studies; Treatment Outcome; Vinorelbine | 2018 |
Emergence of anti-mitochondrial M2 antibody in patient with angioimmunoblastic T-cell lymphoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Autoantibodies; Cyclophosphamide; Etoposide; Female; Hepatomegaly; Humans; Immunoblastic Lymphadenopathy; Liver; Lymphoma, T-Cell; Mitochondria; Prednisone; Procarbazine; Splenomegaly | 2018 |
The Prognostic Role of Circulating Epstein-Barr Virus DNA Copy Number in Angioimmunoblastic T-Cell Lymphoma Treated with Dose-Adjusted EPOCH.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; DNA Copy Number Variations; DNA, Viral; Doxorubicin; Epstein-Barr Virus Infections; Etoposide; Female; Herpesvirus 4, Human; Humans; Lymphocyte Count; Lymphoma, T-Cell; Male; Middle Aged; Prednisone; Prognosis; Retrospective Studies; Survival Analysis; Treatment Outcome; Vincristine | 2019 |
A Case of Refractory Subcutaneous Panniculitis-like T-cell Lymphoma with Bone Marrow and Lung Involvement Treated Successfully with Oral Etoposide.
Topics: Administration, Oral; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Biomarkers, Tumor; Biopsy; Bone Marrow Neoplasms; Etoposide; Humans; Immunohistochemistry; Lung Neoplasms; Lymphoma, T-Cell; Male; Panniculitis; Treatment Outcome | 2018 |
47-Year-Old Man With Pancytopenia and Fever.
Topics: Anemia; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Diagnosis, Differential; Doxorubicin; Etoposide; Felty Syndrome; Fever; Humans; Lymphoma, T-Cell; Male; Methylprednisolone; Middle Aged; Pancytopenia; Prednisolone; Splenomegaly; Vincristine | 2019 |
A case of CD20-positive peripheral T-cell lymphoma treated with rituximab and multiagent chemotherapy.
Topics: Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Humans; Lymphoma, T-Cell; Methylprednisolone; Prednisone; Rituximab; T-Lymphocytes; Vincristine | 2014 |
Successful treatment of hepatosplenic T-cell lymphoma with ESHAP followed by autologous stem cell transplant.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Etoposide; Female; Humans; Liver; Lymphoma, T-Cell; Methylprednisolone; Spleen; Stem Cell Transplantation; Transplantation, Autologous; Treatment Outcome | 2013 |
Quantification of circulating Epstein-Barr virus DNA in NK/T-cell lymphoma treated with the SMILE protocol: diagnostic and prognostic significance.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Dexamethasone; DNA, Viral; Etoposide; Female; Herpesvirus 4, Human; Humans; Ifosfamide; Killer Cells, Natural; Lymphoma, T-Cell; Male; Methotrexate; Middle Aged; Prognosis | 2014 |
Allogeneic stem cell transplantation with BEAM and alemtuzumab conditioning immediately after remission induction has curative potential in advanced T-cell non-Hodgkin's lymphoma.
Topics: Adult; Aged; Alemtuzumab; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Child; Cytarabine; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, T-Cell; Male; Melphalan; Middle Aged; Remission Induction; Transplantation Chimera; Transplantation Conditioning; Transplantation, Homologous | 2013 |
Angioimmunoblastic T cell lymphoma: an unusual presentation of posttransplant lymphoproliferative disorder in a pediatric patient.
Topics: Alveolitis, Extrinsic Allergic; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Child; Cyclophosphamide; Cytarabine; Etoposide; Heart Transplantation; Humans; Hydrocortisone; Immunoblastic Lymphadenopathy; Immunocompromised Host; Immunophenotyping; Immunosuppressive Agents; Kartagener Syndrome; Lymphoma, T-Cell; Methotrexate; Mycophenolic Acid; Oculomotor Nerve Diseases; Postoperative Complications; Prednisone; Remission Induction; T-Lymphocyte Subsets; Tacrolimus; Vincristine | 2014 |
Two-faced haemophagocytic lymphohistiocytosis: comparative review of two cases of adult haemophagocytic lymphohistiocytosis.
Topics: Adult; Anti-Inflammatory Agents; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents, Phytogenic; Biopsy, Fine-Needle; Cyclosporine; Dexamethasone; Diagnosis, Differential; Epstein-Barr Virus Infections; Etoposide; Female; Histiocytes; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Lymphohistiocytosis, Hemophagocytic; Lymphoma, T-Cell; Male; Middle Aged; Rituximab; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
SIE-SIES-GITMO guidelines for the management of adult peripheral T- and NK-cell lymphomas, excluding mature T-cell leukaemias.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Evidence-Based Medicine; Humans; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Practice Guidelines as Topic; Prednisolone; Prednisone; Vincristine | 2014 |
Familial haemophagocytic lymphohistiocytosis: Australian experience and perspectives.
Topics: Antibodies, Monoclonal, Murine-Derived; Cyclosporine; Dexamethasone; Epstein-Barr Virus Infections; Etoposide; Female; Humans; Lymphohistiocytosis, Hemophagocytic; Lymphoma, T-Cell; Male | 2014 |
NK/T cell lymphoma associated with peripheral eosinophilia.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Eosinophilia; Etoposide; Humans; Killer Cells, Natural; Lymphoma, T-Cell; Male; Prednisone; Radiography; T-Lymphocytes; Thoracic Wall | 2014 |
[Non-upper aerodigestive tract NK/T- cell lymphoma: an analysis of clinical features and survival from a single center in China].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lymphoma, T-Cell; Male; Middle Aged; Prednisone; Prognosis; Retrospective Studies; Salvage Therapy; Survival Rate; Treatment Outcome; Vincristine; Young Adult | 2015 |
Cytomegalovirus Pneumonia after Anti-CC-chemokine Receptor 4 Monoclonal Antibody (Mogamulizumab) Therapy in an Angioimmunoblastic T-cell Lymphoma Patient.
Topics: Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Cisplatin; Cyclophosphamide; Cytarabine; Cytomegalovirus Infections; Disease Progression; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Fatal Outcome; Humans; Immunoblastic Lymphadenopathy; Lymphoma, T-Cell; Male; Methylprednisolone; Middle Aged; Pneumonia, Viral; Prednisone; Receptors, CCR4; Vincristine | 2016 |
[Retrospective analyses of CHOPE plus L-asparaginase regimen in treatment of T-cell lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Comparative Effectiveness Research; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Lymphoma, Extranodal NK-T-Cell; Lymphoma, T-Cell; Prednisone; Prognosis; Remission Induction; Retrospective Studies; Survival Rate; Treatment Outcome; Vincristine | 2016 |
Ongoing remission after intensive ALL-type chemotherapy in pediatric intestinal T-cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Doxorubicin; Etoposide; Humans; Intestinal Neoplasms; Lymphoma, T-Cell; Male; Mercaptopurine; Methotrexate; Methylprednisolone; Neoplasm Staging; Receptors, Antigen, T-Cell, gamma-delta; Remission Induction; Thioguanine; Vincristine | 2010 |
Hepatosplenic alphabeta T cell lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bone Marrow Transplantation; Carboplatin; Cisplatin; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Fatal Outcome; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Liver Neoplasms; Lymphoma, T-Cell; Male; Methylprednisolone; Positron-Emission Tomography; Prednisolone; Receptors, Antigen, T-Cell, alpha-beta; Splenic Neoplasms; T-Lymphocytes; Tomography, X-Ray Computed; Transplantation Conditioning; Vincristine | 2010 |
Schedule-dependent inhibition of T-cell lymphoma cells by cotreatment with the mTOR inhibitor everolimus and anticancer drugs.
Topics: Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Boronic Acids; Bortezomib; Cell Cycle; Cell Proliferation; Dose-Response Relationship, Drug; Doxorubicin; Drug Synergism; Etoposide; Everolimus; Humans; Jurkat Cells; Lymphoma, T-Cell; Phosphorylation; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Pyrazines; Sirolimus; Time Factors; TOR Serine-Threonine Kinases; Vincristine | 2012 |
High survival rate in childhood non-Hodgkin lymphoma without CNS involvement: results of BFM 95 study in Kuwait.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Burkitt Lymphoma; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Infant; Kuwait; Leucovorin; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Male; Mercaptopurine; Mesna; Methotrexate; Neoplasm Staging; Prednisolone; Prednisone; Survival Rate; Thioguanine; Treatment Outcome; Vincristine | 2003 |
Enteropathy-type T-cell lymphoma showing repeated small bowel rupture and refractoriness to chemotherapy: a case report.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Intestinal Fistula; Intestinal Neoplasms; Intestinal Perforation; Jejunal Diseases; Lymphoma, T-Cell; Male; Prednisone; Rupture, Spontaneous; Vincristine | 2002 |
[Immunoblastic lymphadenopathy-like T cell lymphoma with high level of serum interleukin-2 and various allergic reactions].
Topics: Anemia, Hemolytic, Autoimmune; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dermatitis, Allergic Contact; Doxorubicin; Etoposide; Humans; Hypergammaglobulinemia; Immunoblastic Lymphadenopathy; Immunoglobulin E; Interleukin-2; Lymphoma, T-Cell; Male; Middle Aged; Prednisone; Treatment Outcome; Vincristine | 2002 |
Primary colorectal T-cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Barium Sulfate; Bleomycin; Colonoscopy; Colorectal Neoplasms; Cyclophosphamide; Cytarabine; Diagnosis, Differential; Doxorubicin; Enema; Etoposide; Humans; Lymphoma, T-Cell; Male; Methotrexate; Middle Aged; Prednisone; Vincristine | 2003 |
Esophageal actinomycosis after allogeneic peripheral blood stem cell transplantation for extranodal natural killer/T cell lymphoma, nasal type.
Topics: Actinomycosis; Adult; Busulfan; Cyclophosphamide; Esophageal Diseases; Etoposide; Humans; Immunosuppressive Agents; Killer Cells, Natural; Lymphoma, T-Cell; Male; Peripheral Blood Stem Cell Transplantation; Time Factors; Transplantation Conditioning; Transplantation, Homologous | 2003 |
[Abscopal effect of small intestinal NK/T-cell lymphoma].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Intestinal Neoplasms; Intestine, Small; Killer Cells, Natural; Lymphoma, T-Cell; Prednisone; Radiotherapy Dosage; Remission Induction; Vincristine | 2003 |
Effective high-dose chemotherapy combined with CD34+-selected peripheral blood stem cell transplantation in a patient with cutaneous involvement of nasal NK/T-cell lymphoma.
Topics: Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Humans; Lymphoma, T-Cell; Middle Aged; Skin Neoplasms; Stem Cell Transplantation; Treatment Outcome; Whole-Body Irradiation | 2004 |
Extranodal multiple involvement of enteropathy-type T-cell lymphoma without expression of CC chemokine receptor 7.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cell Movement; Cisplatin; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Fatal Outcome; Humans; Immunophenotyping; Intestinal Mucosa; Intestinal Neoplasms; Intestine, Small; Lymph Nodes; Lymphoma, T-Cell; Male; Methylprednisolone; Neoplasm Invasiveness; Neoplastic Stem Cells; Organ Specificity; Pleural Effusion; Prednisone; Receptors, CCR7; Receptors, Chemokine; T-Lymphocyte Subsets; Vincristine; Viscera | 2004 |
Successful treatment of disseminated nasal T-cell lymphoma using high-dose chemotherapy and autologus peripheral blood stem cell transplantation: a case report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Follow-Up Studies; Humans; Lymphoma, T-Cell; Male; Mitoxantrone; Nasal Cavity; Nose Neoplasms; Peripheral Blood Stem Cell Transplantation; Prednisolone; Prednisone; Salvage Therapy; Tomography, X-Ray Computed; Transplantation, Autologous; Treatment Outcome; Vincristine | 2004 |
[Results of intensive chemotherapy followed by hematopoietic stem-cell rescue in 22 patients with refractory or recurrent primary CNS lymphoma or intraocular lymphoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Central Nervous System Neoplasms; Combined Modality Therapy; Cytarabine; Etoposide; Eye Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Large-Cell, Immunoblastic; Lymphoma, T-Cell; Middle Aged; Prognosis; Recurrence; Thiotepa | 2004 |
[CD56-positive peripheral T-cell lymphoma primarily presenting with tonsillar swelling].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; CD56 Antigen; Cyclophosphamide; Etoposide; Fatal Outcome; Female; Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor; Humans; Ileal Neoplasms; Lymphoma, T-Cell; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Nitrosourea Compounds; Peripheral Blood Stem Cell Transplantation; Remission Induction; Tonsillar Neoplasms; Transplantation, Autologous | 2004 |
IMVP-16/Pd followed by high-dose chemotherapy and autologous stem cell transplantation as a salvage therapy for refractory or relapsed peripheral T-cell lymphomas.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Lymphoma, T-Cell; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Recurrence; Retrospective Studies; Salvage Therapy; Stem Cell Transplantation; Survival Analysis; Treatment Outcome; Vincristine | 2005 |
[MINE regimen for patients with relapsed or chemo-resistant invasive non-Hodgkin's lymphoma].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Drug Resistance, Neoplasm; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Leukopenia; Lymphoma, B-Cell; Lymphoma, T-Cell; Male; Middle Aged; Mitoguazone; Recurrence; Remission Induction; Retrospective Studies; Survival Rate; Thrombocytopenia; Vinblastine | 2005 |
[Prognostic analysis of patients with nasal-type NK/T-cell non-Hodgkin's lymphoma--a report of 93 cases].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anemia; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Killer Cells, Natural; Lymphoma, T-Cell; Male; Middle Aged; Neoplasm Staging; Neutropenia; Nose Neoplasms; Prednisone; Prognosis; Remission Induction; Retrospective Studies; Survival Rate; Vincristine | 2005 |
[Angioimmunoblastic T-cell lymphoma occurring four months after autologous peripheral blood stem cell transplantation with high-dose chemotherapy for follicular lymphoma].
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Etoposide; Female; Humans; Immunoblastic Lymphadenopathy; Lymphoma, Follicular; Lymphoma, T-Cell; Middle Aged; Peripheral Blood Stem Cell Transplantation; Prednisone; Pulse Therapy, Drug; Time Factors; Transplantation, Autologous; Treatment Outcome; Vincristine | 2005 |
First-line ifosfamide, methotrexate, etoposide and prednisolone chemotherapy +/- radiotherapy is active in stage I/II extranodal NK/T-cell lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Disease-Free Survival; Etoposide; Female; Humans; Ifosfamide; Lymphoma, T-Cell; Male; Methotrexate; Middle Aged; Prednisolone; Remission Induction; Time Factors; Treatment Outcome | 2006 |
Successful treatment of refractory subcutaneous panniculitis-like T-cell lymphoma with allogeneic peripheral blood stem cell transplantation from HLA-mismatched sibling donor.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Histocompatibility Testing; HLA Antigens; Humans; Lymphoma, T-Cell; Panniculitis; Peripheral Blood Stem Cell Transplantation; Prednisone; Siblings; Tissue Donors; Transplantation, Homologous; Vincristine | 2006 |
[Efficacy of DICE (dexamethasone, etoposide, ifosfamide, and cisplatin) regimen on recurrent and refractory non-Hodgkin's lymphoma].
Topics: Adult; Aged; Aged, 80 and over; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dexamethasone; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Male; Middle Aged; Nausea; Neoplasm Recurrence, Local; Remission Induction; Salvage Therapy; Thrombocytopenia; Young Adult | 2006 |
[A case of CD56 positive T-cell lymphoma originating from mediastinal lymph nodes].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; CD56 Antigen; Cyclophosphamide; Dexamethasone; Diagnosis, Differential; Doxorubicin; Etoposide; Humans; Ifosfamide; Lymph Nodes; Lymphoma, T-Cell; Male; Mediastinal Neoplasms; Middle Aged; Pleural Effusion, Malignant; Prednisolone; Tuberculosis, Pleural; Vincristine | 2006 |
Autologous hematopoietic stem cell transplantation in peripheral T-cell lymphoma using a uniform high-dose regimen.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Cyclophosphamide; Disease-Free Survival; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, B-Cell; Lymphoma, T-Cell; Male; Middle Aged; Retrospective Studies; Survival Rate; Transplantation Conditioning; Transplantation, Autologous | 2007 |
In vivo targeting of dead tumor cells in a murine tumor model using a monoclonal antibody specific for the La autoantigen.
Topics: Animals; Antibodies, Monoclonal; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Apoptosis; Autoantigens; Combined Modality Therapy; Cyclophosphamide; DNA Damage; Etoposide; Flow Cytometry; Fluorescent Antibody Technique; Immunoblotting; Immunoconjugates; Indium Radioisotopes; Lymphoma, T-Cell; Mice; Mice, Inbred C57BL; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Radioimmunotherapy; Ribonucleoproteins; SS-B Antigen; Thymus Gland; Tissue Distribution; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2007 |
Visual hallucinations following treatment with vincristine.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Cyclophosphamide; Doxorubicin; Etoposide; Hallucinations; Humans; Lymphoma, T-Cell; Male; Melphalan; Methotrexate; Middle Aged; Multiple Myeloma; Prednisolone; Prednisone; Procarbazine; Salvage Therapy; Serotonin; Structure-Activity Relationship; Vincristine | 1994 |
[Secondary leukemia after etoposide treatment involved MLL gene rearrangement].
Topics: Chromosomes, Human, Pair 11; Etoposide; Gene Rearrangement; Humans; Leukemia, Myeloid, Acute; Lymphoma, T-Cell; Male; Middle Aged; Neoplasms, Second Primary; Translocation, Genetic | 1994 |
[Immunoblastic lymphadenopathy-like T cell lymphoma associated with erythroid hypoplasia and thrombocytopenia].
Topics: Aged; Anemia, Aplastic; Antineoplastic Combined Chemotherapy Protocols; Autoantibodies; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Immunoblastic Lymphadenopathy; Lymphoma, T-Cell; Thrombocytopenia | 1996 |
Antiblastic chemotherapy drugs up-modulate interferon-gamma receptor expression on human malignant T cells.
Topics: Antineoplastic Agents; Apoptosis; Cell Division; Cisplatin; Cytarabine; Daunorubicin; Etoposide; Flow Cytometry; Interferon gamma Receptor; Leukemia-Lymphoma, Adult T-Cell; Lymphoma, T-Cell; Neoplastic Stem Cells; Receptors, Interferon; T-Lymphocytes; Tumor Cells, Cultured; Up-Regulation | 1997 |
CD3- CD56+ non-Hodgkin's lymphomas with an aggressive behavior related to multidrug resistance.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bone Marrow Transplantation; CD3 Complex; CD56 Antigen; Cell Nucleus; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Etoposide; Fatal Outcome; Female; Femoral Neoplasms; Herpesvirus 4, Human; Humans; Idarubicin; Immunophenotyping; Killer Cells, Natural; Lymphoma, Large-Cell, Immunoblastic; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Male; Methylprednisolone; Neoplasm Invasiveness; Neoplasm Proteins; Neoplastic Stem Cells; Pelvic Neoplasms; Prednisone; Quinine; Vincristine | 1997 |
A lymphoma cell line resistant to 4-piperidinopiperidine was less sensitive to CPT-11.
Topics: Antineoplastic Agents; Camptothecin; Cell Division; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; Drug Resistance, Neoplasm; Etoposide; Humans; Irinotecan; Lymphoma, T-Cell; Piperidines; Tumor Cells, Cultured | 1997 |
[Combination chemotherapy with BH-AC, mitoxantrone, etoposide, and prednisolone to refractory or relapsed malignant lymphoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Drug Administration Schedule; Etoposide; Female; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, T-Cell; Male; Middle Aged; Mitoxantrone; Prednisolone | 1997 |
Contribution of gene-specific lesions, DNA-replication-associated damage, and subsequent transcriptional inhibition in topoisomerase inhibitor-mediated apoptosis in lymphoma cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Camptothecin; Cell Transformation, Viral; Chickens; Dactinomycin; DNA Damage; DNA Replication; DNA, Ribosomal; Etoposide; Genes, myc; Kinetics; Lymphoma, B-Cell; Lymphoma, T-Cell; Topoisomerase I Inhibitors; Transcription, Genetic; Tumor Cells, Cultured | 1998 |
Secondary acute myeloid leukemia following treatment with VP16-containing regimens for non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Doxorubicin; Enzyme Inhibitors; Etoposide; Fatal Outcome; Female; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Leukemia, Monocytic, Acute; Leukemia, Myelomonocytic, Acute; Lymphoma, Large B-Cell, Diffuse; Lymphoma, T-Cell; Male; Methotrexate; Mitoxantrone; Neoplasm Proteins; Neoplasms, Second Primary; Prednisone; Topoisomerase II Inhibitors; Vincristine | 1998 |
T-cell-rich B-cell non-Hodgkin's lymphoma mimicking Hodgkin's disease.
Topics: Adult; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Diagnosis, Differential; Doxorubicin; Etoposide; Humans; Immunophenotyping; Lymph Nodes; Lymphoma, B-Cell; Lymphoma, T-Cell; Male; Neoplasm Staging; Recurrence; T-Lymphocytes; Vincristine | 1999 |
Overexpression of Ras, Raf and L-myc but not Bcl-2 family proteins is linked with resistance to TCR-mediated apoptosis and tumorigenesis in thymic lymphomas from TCR transgenic mice.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Calcium; Etoposide; Female; Gene Expression Regulation, Neoplastic; Genes, bcl-2; Genes, myc; Genes, ras; H-Y Antigen; Humans; Lymphoma, T-Cell; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neoplasm Proteins; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-myc; Proto-Oncogene Proteins c-raf; Proto-Oncogene Proteins p21(ras); Receptors, Antigen, T-Cell; Signal Transduction; Thymus Neoplasms; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2000 |
Involvement of the appendix in a relapsed case of primary nasal NK/T-cell lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Appendectomy; Appendiceal Neoplasms; Appendicitis; Bleomycin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Epstein-Barr Virus Infections; Etoposide; Humans; Intestinal Perforation; Killer Cells, Natural; Leucovorin; Lymphoma, T-Cell; Male; Methotrexate; Methylprednisolone; Nitrosourea Compounds; Nose Neoplasms; Prednisone; Skin Neoplasms; Splenic Neoplasms; Tumor Virus Infections; Vincristine | 2000 |
Recurrent penicillin-resistant pneumococcal sepsis after matched unrelated donor (MUD) transplantation for refractory T cell lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bacteremia; Bone Marrow Transplantation; Carmustine; Cefotaxime; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Cytomegalovirus Infections; Doxorubicin; Drug Therapy, Combination; Etoposide; Humans; Idarubicin; Immunocompromised Host; Immunosuppressive Agents; Levofloxacin; Lymphoma, T-Cell; Male; Melphalan; Ofloxacin; Penicillin Resistance; Pneumococcal Infections; Prednisone; Recurrence; Rifampin; Splenectomy; Streptococcus pneumoniae; Transplantation Conditioning; Vincristine | 2000 |
Long-term administration of oral low-dose topoisomerase II inhibitors, MST-16 and VP-16, for refractory or relapsed non-Hodgkin's lymphoma.
Topics: Administration, Oral; Adult; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Drug Resistance, Neoplasm; Etoposide; Female; Follow-Up Studies; Humans; Lymphoma, B-Cell; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Male; Middle Aged; Piperazines; Recurrence; Topoisomerase II Inhibitors | 2000 |
Leukocytoclastic vasculitis with IgA deposits in angioimmunoblastic T cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Diagnosis, Differential; DNA Primers; Doxorubicin; Etoposide; Herpesvirus 4, Human; Humans; Immunoblastic Lymphadenopathy; Immunoglobulin A; In Situ Hybridization; Lymphoma, T-Cell; Male; Middle Aged; Polymerase Chain Reaction; Prednisone; Purpura | 2001 |
Primary bilateral T-cell renal lymphoma presenting with sudden loss of renal function.
Topics: Acute Kidney Injury; Antineoplastic Combined Chemotherapy Protocols; Autoantibodies; Bell Palsy; Bleomycin; Creatinine; Cyclophosphamide; Doxorubicin; Etoposide; Fatal Outcome; Humans; Kidney Neoplasms; Lymphoma, T-Cell; Male; Middle Aged; Vincristine | 2001 |
In vitro induction of apoptosis for nasal angiocentric natural killer cell lymphoma-derived cell line, NK-YS, by etoposide and cyclosporine A.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; ATP Binding Cassette Transporter, Subfamily B; Cyclosporine; Drug Resistance, Neoplasm; Etoposide; Herpesvirus 4, Human; Humans; Immunosuppressive Agents; Killer Cells, Natural; Lymphoma, T-Cell; Nucleic Acid Synthesis Inhibitors; Proto-Oncogene Proteins c-bcl-2; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2001 |
[T-cell rich B-cell lymphoma associated with hemophagocytic syndrome].
Topics: Adult; Agranulocytosis; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Autopsy; Bleomycin; Bone Marrow; Cyclophosphamide; Doxorubicin; Etoposide; Granulocyte-Macrophage Colony-Stimulating Factor; Histiocytosis, Non-Langerhans-Cell; HLA-DR Antigens; Humans; Liver Neoplasms; Lymph Nodes; Lymphoma, T-Cell; Macrophages; Male; Prednisone; Splenic Neoplasms; Vincristine | 1992 |
[Immunoblastic lymphadenopathy-like T cell lymphoma accompanied by autoimmune hemolytic anemia].
Topics: Anemia, Hemolytic, Autoimmune; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Immunoblastic Lymphadenopathy; Lymphoma, T-Cell; Male; Middle Aged; Prednisolone; Remission Induction | 1992 |